Shar Rao was born and raised in Bengaluru, India and moved to the Netherlands at the age of 19 to pursue a Bachelor of Science at University College Utrecht. They specialised in Medicinal Biochemistry and Cognitive Neuroscience, and minored in Performance Studies. They then went on to complete a Master of Science in Drug Innovation at Utrecht University. Currently, they are pursuing their PhD, focusing on the regulatory pathways for patient access to psychedelic therapies. In their free time, they enjoy reading fantasy novels, dancing, and playing the piano.
Christine Hallgreen,
Principal Investigator
Christine Erikstrup Hallgreen is Associate Professor in Pharmaceutical Regulatory Science at the University of Copenhagen. Her research focuses on regulatory decision-making, clinical evidence standards, benefit–risk assessment, and post-authorisation evidence generation. Within INTEGRATE, she contributes expertise in regulatory pathways for psychedelic therapies, including approval strategies, controlled-substance constraints, and early access mechanisms. Her approach is grounded in the principle that regulatory systems for medicines, like medicines themselves, should be safe, effective, efficient, and demonstrably beneficial to patients and society.
